These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
851 related articles for article (PubMed ID: 21900882)
21. Combination strategy employing BACE1 inhibitor and memantine to boost cognitive benefits in Alzheimer's disease therapy. Tarif AMM; Huhe H; Ohno M Psychopharmacology (Berl); 2024 May; 241(5):975-986. PubMed ID: 38197930 [TBL] [Abstract][Full Text] [Related]
22. Sex- and brain region-specific acceleration of β-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease. Devi L; Alldred MJ; Ginsberg SD; Ohno M Mol Brain; 2010 Nov; 3():34. PubMed ID: 21059265 [TBL] [Abstract][Full Text] [Related]
23. Deletion of the eIF2α Kinase GCN2 fails to rescue the memory decline associated with Alzheimer's disease. Devi L; Ohno M PLoS One; 2013; 8(10):e77335. PubMed ID: 24146979 [TBL] [Abstract][Full Text] [Related]
24. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence. Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825 [TBL] [Abstract][Full Text] [Related]
25. PERK mediates eIF2α phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer's disease. Devi L; Ohno M Neurobiol Aging; 2014 Oct; 35(10):2272-81. PubMed ID: 24889041 [TBL] [Abstract][Full Text] [Related]
26. Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model. Li W; Yu J; Liu Y; Huang X; Abumaria N; Zhu Y; Huang X; Xiong W; Ren C; Liu XG; Chui D; Liu G Mol Brain; 2014 Sep; 7():65. PubMed ID: 25213836 [TBL] [Abstract][Full Text] [Related]
27. Hydrogen sulfide down-regulates BACE1 and PS1 via activating PI3K/Akt pathway in the brain of APP/PS1 transgenic mouse. He XL; Yan N; Chen XS; Qi YW; Yan Y; Cai Z Pharmacol Rep; 2016 Oct; 68(5):975-82. PubMed ID: 27372924 [TBL] [Abstract][Full Text] [Related]
28. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199 [TBL] [Abstract][Full Text] [Related]
29. 1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer's Disease Mice. Jeong YJ; Kang GY; Kwon JH; Choi HD; Pack JK; Kim N; Lee YS; Lee HJ Curr Alzheimer Res; 2015; 12(5):481-92. PubMed ID: 26017559 [TBL] [Abstract][Full Text] [Related]
30. BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis. Zhang S; Wang Z; Cai F; Zhang M; Wu Y; Zhang J; Song W J Neurosci; 2017 Jul; 37(29):6915-6925. PubMed ID: 28626014 [TBL] [Abstract][Full Text] [Related]
31. Protective effects of 7,8-dihydroxyflavone on neuropathological and neurochemical changes in a mouse model of Alzheimer's disease. Aytan N; Choi JK; Carreras I; Crabtree L; Nguyen B; Lehar M; Blusztajn JK; Jenkins BG; Dedeoglu A Eur J Pharmacol; 2018 Jun; 828():9-17. PubMed ID: 29510124 [TBL] [Abstract][Full Text] [Related]
32. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932 [TBL] [Abstract][Full Text] [Related]
33. Genetic inhibition of phosphorylation of the translation initiation factor eIF2α does not block Aβ-dependent elevation of BACE1 and APP levels or reduce amyloid pathology in a mouse model of Alzheimer's disease. Sadleir KR; Eimer WA; Kaufman RJ; Osten P; Vassar R PLoS One; 2014; 9(7):e101643. PubMed ID: 24992504 [TBL] [Abstract][Full Text] [Related]
34. Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia. Yang YJ; Li YK; Wang W; Wan JG; Yu B; Wang MZ; Hu B Pharmacol Biochem Behav; 2014 Jul; 122():30-6. PubMed ID: 24662915 [TBL] [Abstract][Full Text] [Related]
35. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation. Bao XQ; Li N; Wang T; Kong XC; Tai WJ; Sun H; Zhang D PLoS One; 2013; 8(11):e78033. PubMed ID: 24223757 [TBL] [Abstract][Full Text] [Related]
36. Swedish mutant APP-based BACE1 binding site peptide reduces APP β-cleavage and cerebral Aβ levels in Alzheimer's mice. Li S; Hou H; Mori T; Sawmiller D; Smith A; Tian J; Wang Y; Giunta B; Sanberg PR; Zhang S; Tan J Sci Rep; 2015 Jun; 5():11322. PubMed ID: 26091071 [TBL] [Abstract][Full Text] [Related]
37. Salvianolic acid B ameliorates retinal deficits in an early-stage Alzheimer's disease mouse model through downregulating BACE1 and Aβ generation. Wang MD; Zhang S; Liu XY; Wang PP; Zhu YF; Zhu JR; Lv CS; Li SY; Liu SF; Wen L Acta Pharmacol Sin; 2023 Nov; 44(11):2151-2168. PubMed ID: 37420104 [TBL] [Abstract][Full Text] [Related]
38. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases. Cai Z; Wang C; He W; Chen Y Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345 [TBL] [Abstract][Full Text] [Related]
39. Regulation of Synaptic Amyloid-β Generation through BACE1 Retrograde Transport in a Mouse Model of Alzheimer's Disease. Ye X; Feng T; Tammineni P; Chang Q; Jeong YY; Margolis DJ; Cai H; Kusnecov A; Cai Q J Neurosci; 2017 Mar; 37(10):2639-2655. PubMed ID: 28159908 [TBL] [Abstract][Full Text] [Related]